TNF and fatty liver disease: In metabolic disorders such as fatty liver disease, MET improves fatty liver by inhibiting the expression of TNF-α in the liver, suppressing lipid accumulation, and reducing ATP consumption, leading to the reversal of hepatomegaly, lipid degeneration, and abnormal liver enzymes51.